Northwind Medical is a clinical-stage pharmaceutical company focused on the development and commercialization of targeted neuromodulation therapies to treat chronic diseases caused by overactive sympathetic nerves: atrial fibrillation, pulmonary hypertension, chronic obstructive pulmonary disease and chronic pain.